NO970292L - Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener - Google Patents

Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener

Info

Publication number
NO970292L
NO970292L NO970292A NO970292A NO970292L NO 970292 L NO970292 L NO 970292L NO 970292 A NO970292 A NO 970292A NO 970292 A NO970292 A NO 970292A NO 970292 L NO970292 L NO 970292L
Authority
NO
Norway
Prior art keywords
solid phase
antibody
determination
antigens
multiple antigens
Prior art date
Application number
NO970292A
Other languages
English (en)
Other versions
NO970292D0 (no
Inventor
Ursula-Henrike Wienhues
Cornelia Kruse-Mueller
Eva Hoess
Elke Faatz
Beatus Ofenloch-Haehnle
Christoph Seidel
Michael Wiedmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4430972A external-priority patent/DE4430972A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO970292D0 publication Critical patent/NO970292D0/no
Publication of NO970292L publication Critical patent/NO970292L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
NO970292A 1994-07-25 1997-01-23 Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener NO970292L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4426276 1994-07-25
DE4430972A DE4430972A1 (de) 1994-07-25 1994-08-31 Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene
PCT/EP1995/002919 WO1996003652A1 (de) 1994-07-25 1995-07-24 Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene

Publications (2)

Publication Number Publication Date
NO970292D0 NO970292D0 (no) 1997-01-23
NO970292L true NO970292L (no) 1997-03-13

Family

ID=25938668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970292A NO970292L (no) 1994-07-25 1997-01-23 Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener

Country Status (13)

Country Link
US (3) US6613530B1 (no)
EP (1) EP0772774B1 (no)
JP (1) JP3556228B2 (no)
CN (1) CN1148578C (no)
AT (1) ATE331952T1 (no)
AU (1) AU688953B2 (no)
CA (1) CA2195753C (no)
DE (1) DE59511054D1 (no)
ES (1) ES2268694T3 (no)
FI (1) FI970301L (no)
NO (1) NO970292L (no)
NZ (1) NZ291153A (no)
WO (1) WO1996003652A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003652A1 (de) * 1994-07-25 1996-02-08 Boehringer Mannheim Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
DE19649389A1 (de) 1996-11-29 1998-06-04 Boehringer Mannheim Gmbh Antigenspezifischer IgM-Nachweis
WO1998040744A1 (de) 1997-03-10 1998-09-17 Roche Diagnostics Gmbh Verfahren zur simultanen bestimmung von hiv-antigenen und hiv-antikörpern
EP0922958B1 (de) * 1997-12-11 2002-10-02 Roche Diagnostics GmbH Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
US7897404B2 (en) 2000-09-29 2011-03-01 Roche Diagnostics Operations, Inc. Conjugates of defined stoichiometry
DE10048417A1 (de) * 2000-09-29 2002-04-11 Roche Diagnostics Gmbh Verbindungen mit verzweigtem Linker
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
CA2441228A1 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
ES2268076T3 (es) 2001-08-10 2007-03-16 F. Hoffmann-La Roche Ag Metodo para la fabricacion de microparticulas cargadas de proteinas.
US7235376B2 (en) * 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
US7851209B2 (en) * 2003-04-03 2010-12-14 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in assay devices
DE602004021829D1 (de) * 2003-09-11 2009-08-13 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus
AU2005267607B8 (en) * 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2004304348B2 (en) * 2003-12-18 2009-02-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
ATE504834T1 (de) * 2004-02-19 2011-04-15 Idexx Lab Inc Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
CA2576930C (en) * 2004-06-30 2011-06-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
JP4662988B2 (ja) * 2004-06-30 2011-03-30 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスを検出するための方法および装置
EP2567974A3 (en) 2004-09-22 2013-05-22 Cancer Advances, Inc., Monoclonal antibodies to progastrin
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US20080227111A1 (en) * 2007-03-16 2008-09-18 Sysmex Corporation Reagent kit and method for measuring hcv antibody
ATE516298T1 (de) * 2007-04-20 2011-07-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
ES2421719T3 (es) * 2008-04-21 2013-09-05 Bio Rad Laboratories Antígeno de gliadina recombinante desamidada
EP2389585A2 (en) * 2009-01-22 2011-11-30 Li-Cor, Inc. Single molecule proteomics with dynamic probes
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
TW201217783A (en) 2010-09-15 2012-05-01 Mbio Diagnostics Inc System and method for detecting multiple molecules in one assay
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP3171171B1 (en) 2011-12-05 2018-07-18 Bio-rad Laboratories, Inc. Recombinant deamidated gliadin antigen
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
WO2018191645A1 (en) * 2017-04-14 2018-10-18 The Regents Of The University Of California Methods and devices for performing autoantibody assays
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
IL271427B2 (en) 2017-06-15 2025-08-01 Cancer Advances Inc Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
CN108982832A (zh) * 2018-09-28 2018-12-11 蓝怡科技集团股份有限公司 一种免疫诊断用检测装置
CN110456073B (zh) * 2019-08-21 2023-09-22 广东菲鹏生物有限公司 双抗原夹心检测抗体的方法及试剂盒

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837167A (en) * 1981-01-30 1989-06-06 Centocor, Inc. Immunoassay for multi-determinant antigens using high-affinity
GR850899B (no) * 1984-04-12 1985-11-25 Gen Hospital Corp
DK365785A (da) * 1984-09-17 1986-03-18 Hoffmann La Roche Metalcomplexer
EP0366673B1 (en) * 1987-06-09 1992-09-16 Cambridge Life Sciences Plc Immunoassay method
AU1732988A (en) 1987-08-20 1989-02-23 Mooney Chemicals, Inc. High-solids coating compositions
IE63455B1 (en) * 1987-09-04 1995-04-19 Int Murex Tech Corp Immunoassay and biological constructs for use therein
JPH01163661A (ja) * 1987-10-02 1989-06-27 E I Du Pont De Nemours & Co ＩｇＧ捕捉抗体および多重単クローン性抗体検出系を用いたイムノアツセイ
EP0339695A3 (en) * 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
AU641375B2 (en) * 1988-12-20 1993-09-23 Clarity Technologies Incorporated Synthetic HIV-like peptides, their compositions and uses
JPH02290554A (ja) 1989-02-09 1990-11-30 Meidensha Corp 酵素免疫測定試薬およびその調製方法
CA1340530C (en) 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
EP0411944B1 (en) * 1989-08-04 1998-06-10 BEHRINGWERKE Aktiengesellschaft Heterogeneous binding assays
JPH0389163A (ja) 1989-08-31 1991-04-15 Meidensha Corp 酵素免疫測定用試薬及びその調製方法
JPH0389164A (ja) 1989-08-31 1991-04-15 Meidensha Corp 酵素免疫測定用試薬及びその調製方法
JPH0389165A (ja) 1989-08-31 1991-04-15 Meidensha Corp 酵素免疫測定用試薬及びその調製方法
JPH05126829A (ja) * 1991-04-03 1993-05-21 Syntex Usa Inc 免疫グロブリンのイムノアツセイ
JPH05133952A (ja) * 1991-04-03 1993-05-28 Syntex Usa Inc イムノグロブリン類のイムノアツセイ
DK0608261T3 (da) 1991-09-13 2003-03-17 Chiron Corp Sammensætninger med immunreaktivt hepatitis C virus polypeptid
US5618533A (en) * 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
US5580563A (en) * 1992-05-01 1996-12-03 Tam; James P. Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
US6660276B1 (en) 1994-02-16 2003-12-09 The University Of Virginia Patent Foundation Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
US5804371A (en) * 1994-07-25 1998-09-08 Boehringer Mannheim Gmbh Hapten-labelled peptides
WO1996003652A1 (de) * 1994-07-25 1996-02-08 Boehringer Mannheim Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
DE19723463A1 (de) * 1997-06-04 1998-12-10 Dade Behring Marburg Gmbh Immunchemische Bestimmung von multivalenten Analyten

Also Published As

Publication number Publication date
US20100136519A1 (en) 2010-06-03
CN1148578C (zh) 2004-05-05
US20050074750A1 (en) 2005-04-07
FI970301A0 (fi) 1997-01-24
FI970301A7 (fi) 1997-03-24
ATE331952T1 (de) 2006-07-15
EP0772774A1 (de) 1997-05-14
AU3220495A (en) 1996-02-22
ES2268694T3 (es) 2007-03-16
JPH10504539A (ja) 1998-05-06
EP0772774B1 (de) 2006-06-28
CN1157655A (zh) 1997-08-20
CA2195753C (en) 2008-12-16
FI970301L (fi) 1997-03-24
NZ291153A (en) 1999-01-28
NO970292D0 (no) 1997-01-23
AU688953B2 (en) 1998-03-19
US6613530B1 (en) 2003-09-02
DE59511054D1 (de) 2006-08-10
JP3556228B2 (ja) 2004-08-18
WO1996003652A1 (de) 1996-02-08
CA2195753A1 (en) 1996-02-08
US7629295B2 (en) 2009-12-08

Similar Documents

Publication Publication Date Title
AU688953B2 (en) Determination of a specific immunoglobulin using multiple antigens
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
EP0315364A3 (en) Simultaneous immunoassay for the determination of antigens and antibodies
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
DK165785D0 (da) Immunometrisk bestemmelse rettet mod flere steder
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
EP0310132A3 (en) Immunoassay utilizing igg capture antibody and multiple monoclonal antibody detection system
DE59511101D1 (de) Metallchelat-markierte peptide
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
EP0902286A3 (en) Immunoassay utilizing two incubations with labelled antigen
EP0194158A3 (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
AU636964B2 (en) Immunological detection of metolachlor
ES2061324T3 (es) Complejo aglutinante como reactivo de identificacion de grupo sanguineo.
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
NO903820D0 (no) Fremgangsmaate for paavisning av analytter.
FI843562A0 (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application